Dr. Bechar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7229 Clearvista Dr
Indianapolis, IN 46256Phone+1 317-621-4300Fax+1 317-621-4301
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1994 - 1997
NYU Grossman School of MedicineResidency, Internal Medicine, 1991 - 1994
Ben Gurion University of the NegevClass of 1991
Certifications & Licensure
NY State Medical License 2011 - 2026
IN State Medical License 1996 - 2025
Clinical Trials
- Eribulin Mesylate in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney Dysfunction Start of enrollment: 2006 Oct 23
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
- Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery Start of enrollment: 2010 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- 10 citationsBasic Steps to Building a Research ProgramAllison R. Baer, Naftali Bechar, Gary I. Cohen, Susan Devine
Journal of Oncology Practice. 2010-01-01 - 40 citationsPaclitaxel Plus Bevacizumab in Patients with Chemosensitive Relapsed Small Cell Lung Cancer: A Safety, Feasibility, and Efficacy Study from the Hoosier Oncology GroupShadia I. Jalal, Pablo M. Bedano, Lawrence H. Einhorn, Sumeet Bhatia, Rafat Ansari
Journal of Thoracic Oncology. 2010-12-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
